FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy

Share:

Listens: 0

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

Science

FDA medical oncologists discuss the first approval of a chimeric antigen receptor (CAR) T-cell immunotherapy.